PRGO
PRGO
IE00BGH1M568
Perrigo Company plc
Loading chart...

Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Latest News

Related stocks

DMP.DE
DMP.DE • Germany
Dermapharm Holding SE I
38.4 EUR
2.13B USD 1Y +15.6%
PPGN.SW
PPGN.SW • Switzerland
POLYPEPTIDE N
43.85 CHF
1.74B USD 1Y +68.2%
FAGR.BR
FAGR.BR • Belgium
FAGRON
22.2 EUR
1.83B USD 1Y +10.1%
SFZN.SW
SFZN.SW • Switzerland
SIEGFRIED N
67.5 CHF
3.56B USD 1Y -18.7%
ALVO
ALVO • Luxembourg
Alvotech
5.78 USD
2.06B USD 1Y -34.7%
ALKS
ALKS • Ireland
Alkermes plc
40.61 USD
6.81B USD 1Y +27.3%
HIK.L
HIK.L • United Kingdom
HIKMA PHARMACEUTICALS PLC ORD S
1,612 GBp
4.41B USD 1Y -12.5%
ALM.MC
ALM.MC • Spain
ALMIRALL S.A.
10.08 EUR
2.46B USD 1Y -15.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.5% p.a.
Max Drawdown (5Y)
-80.7%
Sharpe Ratio (5Y)
-0.60
Beta Factor
0.69
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (43.5%) is noticeably higher than the 5Y average (38.5%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -90.3% in the extended horizon.
ende